CORRECTED 10/30/17: The Workers’ Compensation Advisory Council met yesterday in Baton Rouge and took action on the pharmacogenetic testing issue, two months after Council member Bray Williams raised concerns about the practice stemming from the treatment of one of his clients for whom Broadspire was the workers’ comp TPA. Office of Workers’ Compensation Director and WCAC Chair Sheral Kellar and Medical Director Dr. Jason Picard also gave an update on the Medical Treatment Guidelines.
In the following guest post, Carlos Luna, Director of Government Affairs for Reed Group’s MDGuidelines, explores the National Guideline Clearinghouse and whether or not it performs its function – assessing the quality of medical guidelines and improving transparency in the guideline industry. As the Legislature is soon to begin its Regular Session on April 10th and workers’ comp officials anticipate a bill to incorporate the ODG formulary in Louisiana’s system, read on to get Luna’s take on how the National Guideline Clearinghouse could benefit stakeholders across the board.
The meeting of the Workers’ Compensation Advisory Council (WCAC) on February 23rd focused almost exclusively on changes to the Medical Treatment Guidelines (MTGs) Title 40, Chapter 23 and 27, as published in a Notice of Intent (NOI) in the February 2017 edition of the Louisiana Register.
Two bills, one targeting employers who misclassify employees in order to avoid payroll taxes and workers’ comp premiums and another toughening financial solvency standards for group funds, move forward this week. Stick with Louisiana Comp Blog for full coverage of all comp-related legislative happenings until the Session ends on June 6th.
Today (10/28), the Louisiana Workforce Commission (LWC) held a public hearing on the proposed updates to the Medical Treatment Guidelines. The lengthy revisions are primarily based upon Colorado’s MTGs, as were the initial iteration, which took effect in 2011.